Carvalho, Alvaro C. https://orcid.org/0009-0006-9998-3167
Woo, Kimberly P.
Ellis, Ryan C.
Tu, Chao
Miller, Benjamin T.
Prabhu, Ajita S.
Rosen, Michael J.
Krpata, David M.
Petro, Clayton C.
Beffa, Lucas R.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Robotic versus open ventral hernia repair (ROVHR): a randomized controlled trial protocol
https://doi.org/10.1007/s10029-025-03299-7
Article History
Received: 18 November 2024
Accepted: 11 February 2025
First Online: 4 March 2025
Declarations
:
: Alvaro C. Carvalho MD, Lucas R. Beffa MD, Kimberly P. Woo MD Ryan C. Ellis MD and David M. Krpata MD have no disclosures to report. Benjamin T. Miller MD is a consultant for Boston Scientific, received a research grant from the American Hernia Society and research funding from Integra. Clayton C. Petro MD serves as a consultant for Advanced Medical Solutions, TelaBio, Medtronic, Bard-Davol, and Surgimatix, and has received an institutional research grant from Merck. Michael J. Rosen MD serves as the medical director of the ACHQC and receives salary support, received institutional research grants from Telabio and Medtronic.
: Ethical approval for this study was obtained from the Cleveland Clinic Institutional Review Board (IRB# 22-591).
: All participants provided informed consent prior to their participation.
: All procedures performed in this trial are standard of care and are performed by surgeons with appropriate training. This trial complies with the institutional review board and the 1964 Helsinki declaration and its later amendments.